載入...
Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
OBJECTIVE: The Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) trial demonstrated that combination therapy with metformin plus rosiglitazone provided superior durability of glycemic control compared with metformin alone, with significantly lower treatment failure rates (38.6 v...
Na minha lista:
| 格式: | Artigo |
|---|---|
| 語言: | Inglês |
| 出版: |
American Diabetes Association
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3661836/ https://ncbi.nlm.nih.gov/pubmed/23704674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2393 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|